Navigation Links
UMass Medical School researchers awarded pediatric HIV vaccine development grant
Date:4/23/2008

WORCESTER, Mass.The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), a world leader in the fight against pediatric AIDS, announced that it will award five grants totaling $1 million to researchers to support the development of a pediatric HIV vaccine.

Shan Lu, MD, PhD, professor of medicine at the University of Massachusetts Medical School (UMMS), and colleague Katherine Ruiz De Luzuriaga, MD, professor of pediatrics and director of the division of pediatric immunology, are among the first five recipient teams to receive a Pediatric HIV Vaccine Research Program grant. The UMMS team was chosen from 46 teams that competed for the grants; other awardees include researchers at Massachusetts General Hospital; Childrens Hospital Los Angeles; Beth Israel Deaconess Medical Center; and the University of Colorado Health Science Center.

The EGPAF Pediatric HIV Vaccine Research Program supports basic and pre-clinical research relevant to pediatric HIV vaccine design and development. The program was created after a survey of global HIV vaccine projects found that pediatric issues were virtually absent in the research agenda. With a global network of scientists and a long history of supporting pediatric-focused basic research, the Foundation is well positioned to address this gap.

One potentially promising way to reduce the spread of HIV is through a preventive vaccine that will protect all peopleincluding infantsfrom the virus. Vaccines have reduced many common childhood infections by up to 99 percent in the developed world, and may be the single, most effective public health measure. A vaccine that protects infants against HIV transmission through breast-feeding could set the stage for lifetime immunity. If a vaccine succeeds, millions of children could get life-long protection and be part of the first HIV-free generation.

Our awardees are remarkably talented scientists, and their projects will provide critical data that may le
'/>"/>

Contact: Office of Public Affairs
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. UMass Medical School study finds patients diagnosed with coronary heart disease continue poor diets
2. UMass Medical School receives $300,000 from JDRF and Iacocca Foundation
3. UMass Consortium awarded $300,000 from Juvenile Diabetes Research Foundation and Iacocca Foundation
4. UMASS Medical School awarded National Childrens Study contract
5. UMass Medical School study identifies the best weight-loss plans for heart health
6. Chubby Checker Adds Twist to 10,000 Strong at Ninth Annual Walk to Cure Cancer for UMass Memorial Cancer Center at the UMass Medical School
7. WaveMark, Inc. is Chosen by UMass Memorial Medical Center
8. Risk Management: Best Practices for Medical Device Profitability
9. Key Industry and Government Officials to Address Medical Technology Executives
10. Orqis(R) Medical Awarded 15th U.S. Patent
11. Best Practice Database Adds New Research on Effective Sales Force Incentives and Continuing Medical Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)..., Dec. 2 To support medication-sa...um (UHC) and Safecor Health, LLC, announced today ...ment for bar-coded pharmaceutical repackaging serv..., , "UHC is very pleased with the addition ...f agreements and is excited to embark on a partner...
(Date:12/2/2008)...Prevention, Shedding, or Sharing Costs as Key , ...-- A New Center for State and Local Government Exc...etiree health care plans and their need to contain...rican States examines how state administrators pe...its to central human resources (HR) goals; how the...
(Date:12/2/2008)...o 70 Cities and Regions by 2010 , , PRINCET... first investment of a new $44 million initiative,...rded grants of up to $400,000 to nine communities ...s for its most ambitious effort yet to reverse the...ids, Healthy Communities will support local actio...
(Date:12/2/2008)... aprotinin, a drug commonly used to control blood ...ared with lysine analogues, according to a study ...e published in the January 20th issue of CMAJ . ... panel will meet to decide on aprotinin use. The s...ting. , The study, a systematic review of 49 ra...
Breaking Medicine News(10 mins):Health News:UHC and Safecor Health Announce Multi-Year Agreement for Repackaging Bar-Coded Medications 2Health News:States View Limits on Retiree Health Benefits 2Health News:Robert Wood Johnson Foundation Awards Grants to Nine Communities In Launch of $44 Million National Program to Reverse Childhood Obesity 2Health News:Robert Wood Johnson Foundation Awards Grants to Nine Communities In Launch of $44 Million National Program to Reverse Childhood Obesity 3Health News:Robert Wood Johnson Foundation Awards Grants to Nine Communities In Launch of $44 Million National Program to Reverse Childhood Obesity 4
...o scientists Vivian Cheung and Warren Ewens from t...isorders that are recessively inherited. Gene exp...ould differ significantly and this new diagnostic ...echnology to identify differences in genome-wide e...
...ing cattle with many growth hormones that are extr... among EU nations that import beef, necessitating ...expert and a pharmaceutical chemist, John Verrall ...ts of consuming beef from cattle that have been in...
...ers, a woman who lost her husband to AIDS and is n...in her Bihar home. Premila Devi, 40, from Tilaei ...ing into a well Saturday, just a few months after ...d of AIDS. "She was upset by the way her family m...
... babies’ to be overweight, which is thought to be ...’ diet during pregnancy. A study that analyzed nea... UK, the Scottish babies’ weight scored the highes...tuation can be remedied if pregnant women were mad...
Other Medicine News:Health News:New Diagnostic Tool Uncovered Gene Expression Patterns in Recessive Genetic Disorders 2
(Date:12/1/2008)...ARD, Denmark, December 1 ...with the intent to procure an MVA-based,third ge...ment Services,Canada, on behalf of the Canadian D...ract to Bavarian Nordic for the delivery of IMVAMU... use IMVAMUNE(R) as part of the,country,s bio-pre...
(Date:11/30/2008)...ec. 1 Abnormalities in ...in children with autism spectrum disorder by using...y presented today at the annual meeting of the Rad..., "Using MEG, we can record the tiny magnetic fi...aid Timothy Roberts, Ph.D., vice chair of research...
(Date:11/26/2008)...information density, automation and intelligent cl...trasound to an all new level , , CHICAGO, I...Healthcare ( www.siemens.com/healthcare ) highli...Scanner (ABVS)(1), the world,s first multi-use, a...4th Scientific Assembly and Annual Meeting of the ...
(Date:11/25/2008)...FRANCISCO, Calif., Nov. 25 Proteol...nt of novel therapeutics that target,protein degr..., today,announced that data from two ongoing Phas...eloma will be presented at the upcoming 50th Annua...ASH). Carfilzomib is the first in a new class,of...
Breaking Medicine Technology:The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Ohio Company to Debut Turnkey Marketing Material During Florida National Dental Convention 20824 1Ohio Company to Debut Turnkey Marketing Material During Florida National Dental Convention 20824 2Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 1Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 2Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 3Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 4Bamboo instant houses will soon shelter Sichuan quake victims 3504 1Bamboo instant houses will soon shelter Sichuan quake victims 3504 2Is tap water safe for expectant mothers 3F 20821 1Is tap water safe for expectant mothers 3F 20821 2
...therapeutic approach for the treatment,of early an... 2007 /PRNewswire-FirstCall/ - AEterna,Zentaris In...,focused on endocrine therapy and oncology, today ...ts growth hormone-releasing,hormone (GHRH) antagon...ciation for Cancer Research (AACR) Annual Meeting ...
...pr 16, 2007 - Arsenic, a naturally,occurring eleme...r,2,000 years, and even now remains a venerable co..., Today, due in measure to the efforts of investig...ancer Research Foundation,s,(SWCRF) "Institute Wit...ed in therapy for the treatment of certain types o...
Other Medicine Technology:AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 3Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 2Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 3
For determination of HDL-cholesterol in serum and plasma. For Hitachi 717. Specific immunochemical inhibition of non-HDL-lipoproteins. Excellent correlation with established reference methods. Endpoi
Cholesterol/HDL Standard 50 mg/dl.
Intended for the in vitro precipitation of very low density and low density lipoproteins in serum or plasma. Single vial, dry powder precipitating reagent. Total cholesterol reagent not included.
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
Medicine Products: